Enzymatica publ AB (ENZY) — Cash Flow-to-Debt Ratio
Enzymatica publ AB (ENZY) has a Cash Flow-to-Debt Ratio of -0.85x as of September 2025, meaning its operating cash flow of Skr-11.57 Million could theoretically repay -1% of its total liabilities (Skr13.56 Million) in one year. Explore Enzymatica publ AB long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Enzymatica publ AB Cash Flow-to-Debt Ratio (2009–2024)
Historical debt coverage capacity for Enzymatica publ AB across 15 annual periods. Also explore ENZY current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Enzymatica publ AB (2009–2024)
Year-by-year debt coverage analysis for Enzymatica publ AB. For market capitalisation and broader financial context, see ENZY market cap.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.21x | Skr-60.51 Million | Skr18.86 Million | ▼ -292.7% |
| 2023 | -0.82x | Skr-40.29 Million | Skr49.30 Million | ▲ +39.1% |
| 2022 | -1.34x | Skr-64.57 Million | Skr48.12 Million | ▼ -20.0% |
| 2021 | -1.12x | Skr-35.87 Million | Skr32.07 Million | ▼ -481.5% |
| 2020 | -0.19x | Skr-10.65 Million | Skr55.38 Million | ▲ +85.4% |
| 2019 | -1.32x | Skr-37.58 Million | Skr28.51 Million | ▼ -16.8% |
| 2018 | -1.13x | Skr-28.79 Million | Skr25.51 Million | ▼ -15.8% |
| 2017 | -0.97x | Skr-22.55 Million | Skr23.12 Million | ▲ +47.7% |
| 2016 | -1.87x | Skr-38.43 Million | Skr20.60 Million | ▼ -8.4% |
| 2015 | -1.72x | Skr-37.65 Million | Skr21.87 Million | ▲ +58.8% |
| 2014 | -4.17x | Skr-40.67 Million | Skr9.74 Million | ▼ -133.1% |
| 2013 | -1.79x | Skr-18.43 Million | Skr10.29 Million | ▲ +51.5% |
| 2012 | -3.69x | Skr-7.25 Million | Skr1.96 Million | ▼ -1.2% |
| 2011 | -3.65x | Skr-4.86 Million | Skr1.33 Million | ▼ -7501.7% |
| 2009 | -0.05x | Skr-101.99K | Skr2.12 Million | — |